Monitor Q4 2026 for PURE Clean revenue contribution and cash burn rate. The CEO transition and continued dilution from convertible notes suggest limited near-term catalysts. No guidance was issued, so next quarter's results will be critical for trend confirmation.
Price Chart
Executive Summary
PURE Bioscience reported fiscal Q3 2026 revenue of $506,000 (+3% YoY) but net loss widened to $624,000 from $580,000 a year ago. CEO Robert Bartlett announced retirement effective July 31, 2026, with President Jeff Kitchell to succeed. The company continues to burn cash with $983k on hand vs $7.4M in total liabilities, and shares outstanding increased 16% to 130M, reflecting dilution from convertible notes.
Key Financial Metrics
Key Facts
- Fiscal Q3 2026 total revenue $506,000 vs $491,000 YoY (+3.1%)
- Net loss $624,000 vs $580,000 YoY, net loss per share ($0.01) unchanged
- CEO Robert Bartlett retiring July 31, 2026; President Jeff Kitchell to become CEO
- Shares outstanding increased to 130.0M from 111.9M at July 2025 (16% dilution)
- Cash and cash equivalents $983,000 vs $334,000 at July 2025, but convertible notes payable total $6.5M
- PURE Clean launched commercially with initial sales to national food brands
Financial Impact
Revenue growth of $15k YoY in Q3 is immaterial; net loss increase of $44k reflects higher interest expense. No guidance provided.
Risk Factors
- Persistent operating losses with accumulated deficit of $140.9M
- High leverage: $6.5M in convertible notes vs $1.6M in total assets
- Dilution from convertible note conversions (shares up 16% in 9 months)
- CEO transition creates execution risk
- Micro-cap OTC stock with low liquidity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-028686 |
| Document: form8-k.htm | 0001493152-26-028686 |
| Document: 0001493152-26-028686-index-headers.html | 0001493152-26-028686 |
| Document: 0001493152-26-028686-index.html | 0001493152-26-028686 |
| Document: 0001493152-26-028686.txt | 0001493152-26-028686 |
| 8-K Data (Synthetic) | 0001493152-26-028686 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $0.0800 $0.0800 | · 0.00% | ▼ −1.18% | $0.0900 (−12.50%) |
Jun 15, 2026 19w ago | 8-K | $0.0600 $0.0800 | ▲ +33.33% | ▲ +34.58% | $0.0900 (+50.00%) |
May 5, 2026 24w ago | 8-K | $0.0700 $0.0700 | · 0.00% | ▼ −0.33% | $0.0900 (−28.57%) |
Mar 17, 2026 32w ago | 8-K | $0.0800 $0.0800 | · 0.00% | ▲ +1.40% | $0.0900 (+12.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers